Biological markers of suicidal behavior and justification of use level calzidiola in the blood
https://doi.org/10.31363/2313-7053-2019-1-45-51
Abstract
The article is devoted to the problem of search of biomarkers of suicidal behavior and includes literature review, as well as the results of own research of features of suicidal behavior of young age patients with depression (18—27 years) depending on the concentration of calcidiol.
About the Authors
N. N. Petrova
St. Petersburg University
Russian Federation
Russian Federation
V. V. Dorofeykov
Lesgaft National State University of Physical Education, Sport and Health
Russian Federation
Russian Federation
M. V. Dorofeykova
Federal governmental budget institution «National medical research center of psychiatry and neurology n.a. V.M. Bekhterev»
Russian Federation
Russian Federation
M. S. Zadorozhnaya
Psychiatric hospital №1 n.a. P.P. Kaschenko
Russian Federation
Russian Federation
I. V. Kaystrya
Almazov National Medical Research Centre
Russian Federation
Russian Federation
References
1. Dorofeykov V.V., Zadorozhnaya M.S., Petrova N.N. Depression and vitamin D. Psihiatriya. 2014; 2:84- 90. (In Rus.).
2. Zadorozhnaya M.S., Dorofeykov V.V., Petrova N.N. Psychological health and vitamin D(OH). Psikhicheskoye zdorovye. 2017; 2:19-27. (In Rus.).
3. Petrova N.N., Dorofeykov V.V., Varzin S.A. Vitamin D: new knowledge and opportunities for health protection and athletic performance improvement. Teoriya i praktika fizicheskoy kultury. 2016; 11:32-34. (In Rus.).
4. Bertone-Johnson E.R., Powers S.I., Spangler L. et al. Vitamin D intake from foods and supplements and depressive symptoms in a diverse population of older women// Am J Clin Nutr.—2011.—№2.—Р.1104–1112.
5. Bielau H., Mawrin C., Krell D. et al. Differences in activation of the dorsal raphe nucleus depending on performance of suicide // Brain Research.—2005.—Vol.1039.—P.43–52.
6. Cleare A.J., Murray R.M., O’Keane V. Reduced prolactin and cortisol responses to D-fenflura- mine in depressed compared to healthy matched control subjects// Neuropsychopharmacology. – 1996.—№14.—P.349–354.
7. Coccaro E.F, Berman M.E., Kavoussi R.J., Hauger R.L. Relationship of prolactin response to D-fenfluramine to behavioral and questionnaire assessments of aggression in personality-disordered men//Biol. Psychiatry.—1996. -№40.—P.157–164.
8. Coryell W., Schlesser M. The dexamethasone suppression test and suicide prediction // Am. J. Psychiatry. - 2001.—№158.- P.748–753.
9. Deveci A., Aydemir O., Taskin O., Taneli F., Esen-Danaci A. Serum BDNF levels in suicide attempters related to psychosocial stressors: A comparative study with depression // Neuropsychobiology. – 2007.—№56.—P.93–97.
10. Dwivedi Y, Rizavi H.S, Conley R.R, Roberts R.C, Tamminga C.A, Pandey G.N. Altered gene expression of brain-derived neurotrophic factor and receptor tyrosine kinase B in postmortem brain of suicide subjects // Arch Gen Psychiatry. - 2003.—№60.—P.804–815.
11. Eyles D.W., Burne T.H., McGrath J.J. Vitamin D, effects on brain development, adult brain function and the links between low levels of vitamin D and neuropsychiatric disease // Front Neuroendocrinol.—2013.—№34.—Р.47-64.
12. Garcion E., Wion-Barbot N., Montero-Menei C.N., Berger F., Wion D. New clues about vitamin D functions in the nervous system // Trends. Endocrinol. Metab.—2002.—№2.—Р.100–105.
13. Grudet C., Malm J., Westrin A., Brundin L. Suicidal patients are deficient in vitamin D, associated with a pro-inflammatory status in the blood // Psychoneuroendocrinology.—2014.—№50.—Р.210-219.
14. Hogberg G., Gustafsson S.A., Hallstrom T., Gustafsson T., Klawitter B., Petersson M. Depressed adolescents in a case-series were low in vitamin D and depression was ameliorated by vitamin D supplementation // Acta Paediatr.—2012.—№101.—Р.779-783. doi:10.1111/j.1651-2227.2012.02655.x. Epub 2012 Mar 27.
15. Jollant F, Bellivier F, Leboyer M, Astruc B, Tor- res S, Verdier R, Castelnau D, Malafosse A, Courtet P. Impaired decision making in suicide attempters. American Journal of Psychiatry.—2005.—Vol.162.—P.304–310.
16. Kaplan J.R., Muldoon M.F., Manuck S.B et al. Assessing the observed relationship between low cholesterol and violence-related mortality. Implication for suicide risk // Ann. N.Y. Acad. Sci.—1997.—№836.—P.57-80.
17. Khoraminya N., Tehrani-Doost M., Jazayeri S. et al. Therapeutic effects of vitamin D as ad- junctive therapy to fluoxetine in patients with major depressive disorder // Aust. N. Z. J. Psychiatry.—2013.—№47.—P.271-275. doi: 10. 1177 / 0004867412465022. Epub 2012 Oct 23.
18. Kim Y.K., Lee H.P., Won S.D. et al. Low plasma BDNF is associated with suicidal behavior in major depression // Prog. Neuropsychopharmacol. Biol. Psychiatry. – 2007.—№31.—P.78–85.
19. Kim Y.K., Paik J.W., Lee S.W., Yoon D., Han C., Lee B.H. Increased plasma nitric oxide level associated with suicide attempt in depressive pa- tients // Progress in Neuro-psychopharmacology & Biology Psychiatry.—2006.—№30. -P.1091– 1096.
20. Kjærgaard M., Waterloo K., Wang C.E., Almås B., Figenschau Y., Hutchinson M.S., Svartberg J., Jorde R. Effect of vitamin D supplement on depression scores in people with low levels of serum 25-hydroxyvitamin D: nested case-control study and randomised clinical trial // Br J Psychiatry.—2012.—№201.—Р.360-368. doi: 10.1192/bjp.bp.111.104349. Epub 2012 Jul 12.
21. Lee B.H., Lee S.W., Yoon D., Lee H.J., Yang J.C., Shim S.H., Kim D.H., Ryu S.H., Han C., Kim Y.K. Increased plasma nitric oxide metabolites in suicide attempters// Neuropsychobiology.—2006.—№53.—P.127–132.
22. Li G., Mbuagbaw L., Samaan Z., Zhang S., Adachi J.D., Papaioannou A., Thabane L. Efficacy of vitamin D supplementation in depression in adults: a systematic review protocol // Systematic Reviews.—2013.—№2.—Р.757-767. doi: 10.1210/jc.2013-3450. Epub 2013 Dec 11.
23. Lutz P-E., Mechawar N., Turecki G. Neuropathology of suicide: recent Findings and future directions // Molecular Psychiatry advance online publication. July 11 2017. doi:10.1038/mp.2017.141
24. Mallick F., McCullumsmith Ch.B. Ketamine for Treatment of Suicidal Ideation and Reduction of Risk for Suicidal Behavior // Curr Psychiatry Rep. – 2016.—Vol.18.—P.61. doi: 10.1007/s11920-016-0680-7.
25. Malone K.M., Corbitt E.M., Li S., Mann J.J. Prolactin response to fenfluramine and suicide attempt lethality in major depression // Br. J. Psychiatry. - 1996.—№168.—P.324–329.
26. Nanri A., Mizoue T., Matsushita Y., PoudelTandukar K,, Sato M, Ohta M., Mishima N. Association between serum 25-hydroxyvitamin D and depressive symptoms in Japanese: analysis by survey season // Eur J Clin Nutr.—2009.—№2.—Р.1444–1447.
27. Niculescu A, Levey D, Ayalew M. Discovery and validation of blood biomarkers for suicidality // Molecular Psychiatry.—2013.—№18.—P.1249- 1264. doi: 10.1038/mp.2013.95. Epub 2013 Aug 20.
28. Nowak G, Ordway GA, Paul IA. Alterations in the N-methyl-D-aspartate (NMDA) receptor complex in the frontal cortex of suicide victims // Brain Research.—1995. -№675.—P.157–164.
29. Pandey G.N., Ren X., Rizavi H.S., Conley R.R., Roberts R.C., Dwivedi Y. Brain-derived neurotrophic factor and tyrosine kinase B receptor signalling in post-mortem brain of teenage suicide victims // Int. J. Neuropsychopharmacol. – 2008. -№11.—P.1047–1061.
30. Price R.B., Iosifescu D.V., Murrough J.W. et al. Effects of Ketamine on Explicit and Implicit Suicidal Cognition: A Randomized Controlled Trial in Treatment-Resistant Depression // Depress Anxiety. – 2014. - №31.—P.335-343. doi: 10.1002/da.22253. Epub 2014 Mar 25.
31. Runeson B., Odeberg J., Pettersson A., Edbom T., Jildevik Adamsson I., Waern M. Instruments for the assessment of suicide risk: A systematic review evaluating the certainty of the evidence // Abe T. ed. PLoS ONE.—2017.—№12.—e0180292. doi:10.1371/journal.pone.0180292.
32. Tariq M.M., Streeten E.A., Smith H.A., Sl- eemi A., Khabazghazvini B., Vaswani D., Postolache T.T. Vitamin D: a potential role in reducing suicide risk? // Int J Adolesc Med Health.—2011.—№23.—Р.157-165.
33. Tripodianakis J., Markianos M., Sarantidis D., Agouridaki M. Biogenic amine turnover and serum cholesterol in suicide attempt // Eur Arch Psychiatry Clin Neurosci. -2002.—№252.—P.38– 43.
34. Umhau J.C., George D.T., Heaney R.P. Low vitamin D status and suicide: a case-control study of active duty military service members // PLoS One.—2013.—№8.—Р.51-54.
35. van Heeringen K. The neurobiology of suicide and suicidality//Canadia J Psychiatry.—2003.—№48.—P.292–300.
Review
For citations:
Petrova N.N., Dorofeykov V.V., Dorofeykova M.V., Zadorozhnaya M.S., Kaystrya I.V. Biological markers of suicidal behavior and justification of use level calzidiola in the blood. V.M. BEKHTEREV REVIEW OF PSYCHIATRY AND MEDICAL PSYCHOLOGY. 2019;(1):45-51. (In Russ.) https://doi.org/10.31363/2313-7053-2019-1-45-51
Views:
799
Email this article 